Vanda Pharmaceuticals Inc.

AED22.79
AED
Last updated on --.
24h volume884.57K
24h highest23.1766 AED
24h lowest22.4788 AED
24h Price movement+0.24%

VNDA recent prices

24 Hours
+0.24%+AED0.055095
30 days
-8.95%-AED2.234
60 days
-10.71%-AED2.719
90 days
-28.12%-AED8.882

Key data

Previous close22.7359 AED
Market cap1.37B AED
Volume884.57K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-14.6185 AED
Net income (FY)-879.86M AED
Revenue (FY)799.91M AED
Last report dateMay 7, 2026

About Vanda Pharmaceuticals Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersWASHINGTON
Employees (FY)533.00
Revenue per employee (FY)1.50M AED
Net income per employee (FY)-1.65M AED
Listed onNasdaq
Official website

VNDA conversion tables

VNDAVNDA
AEDAED
0.5 VNDA11.39 AED
1 VNDA22.79 AED
5 VNDA113.95 AED
10 VNDA227.9 AED
AEDAED
VNDAVNDA
0.5 AED0.021939 VNDA
1 AED0.043877 VNDA
5 AED0.21939 VNDA
10 AED0.43877 VNDA

FAQ

VNDA is trading at AED22.79, +0.24% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VNDA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VNDA is currently trading at AED22.79, +0.24% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VNDA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VNDA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VNDA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VNDA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Vanda Pharmaceuticals Inc.'s market cap is currently 1.37B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume884.57K
24h highest23.1766 AED
24h lowest22.4788 AED
24h Price movement+0.24%
VNDAVNDA
AEDAED
Start trade with VNDA Perpetual